Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ralph Lauren Corp RL

Consumer Cyclical Luxury Goods
Ralph Lauren Corporation is engaged in the design, marketing, and distribution of luxury lifestyle products, including apparel, footwear & accessories, home, fragrances, and hospitality. Its segments include North America, Europe, and Asia. Its brands include Ralph Lauren, Ralph Lauren Collection, Ralph Lauren Purple Label, Double RL, Polo Ralph Lauren, Lauren Ralph Lauren, Polo Ralph Lauren... see more

Recent & Breaking News (NYSE:RL)

Vitamin D Experts Speak Out on Sunshine

PR Newswire December 16, 2014

Research and Markets: Global Monascus Pigment Industry Report 2014

Business Wire December 16, 2014

Hemispherx's Ampligen(R) Provides Anti-Tumor Activity Analogous to Emerging Immune Checkpoint Inhibitors

GlobeNewswire December 16, 2014

Actavis Announces Proposed Senior Leadership Team Effective Following Completion of Allergan Acquisition

PR Newswire December 16, 2014

Organic and Monascus Pigment Industry 2014 Global Market Research Reports

PR Newswire December 16, 2014

Neovacs Announces Top Line Phase IIb Clinical Trial Results of TNF-Kinoid in Rheumatoid Arthritis and Update on Clinical Programs

GlobeNewswire December 16, 2014

Celldex Announces Completion of Enrollment in Phase 3 Study of Rindopepimut in Frontline Glioblastoma

GlobeNewswire December 15, 2014

Selfie Culture is Here to Stay, and It's Driving Patients Toward Cosmetic Surgery Like Never Before

PR Newswire December 15, 2014

Research and Markets: Melanoma Disease Therapy Review Briefing

Business Wire December 15, 2014

Anthera Pharmaceuticals Licenses Japan Rights for Blisibimod to Zenyaku Kogyo Co., Ltd.

PR Newswire December 15, 2014

VBL Therapeutics Announces Last Patient Out in Phase 2 Clinical Studies of VB-201 in Psoriasis and Ulcerative Colitis

GlobeNewswire December 15, 2014

Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol

PR Newswire December 15, 2014

DELCATH STRENGTHENS BOARD OF DIRECTORS WITH NEW APPOINTMENTS

Thomson Reuters ONE December 15, 2014

Zafgen Announces Initiation of Phase 2b Trial of Beloranib in Severe Obesity

GlobeNewswire December 15, 2014

Experienced Refractive Coordinator Joins Laser Vision Correction Center

GlobeNewswire December 14, 2014

Macrophage Therapeutics to Present Data Supporting Potential for Breakthrough with Manocept(TM) in Immunotherapy

Business Wire December 12, 2014

Immunomedics Reports Expanded Phase 1/2 Trials Confirm Activity and Good Safety Profile of Sacituzumab Govitecan (Immu-132) in Patients With Advanced Triple-Negative Breast Cancer

GlobeNewswire December 12, 2014

Ralph Lauren Corporation Declares Quarterly Dividend

Business Wire December 11, 2014

Fitch Revises Bristol-Myers Squibb's Outlook to Stable; Affirms IDR at 'A-'

Business Wire December 11, 2014

The Association for Molecular Pathology Closes Out 2014 Annual Meeting With Record-Level Attendance

Business Wire December 11, 2014